A review of outcomes of an intracavernosal injection therapy programme

BJU International

Volumn 110, Issue 11, 2012, Pages 1787-1791

  Coombs, Peter G ^a   Heck, Mathias ^a   Guhring, Patricia ^b   Narus, Joseph ^a   Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

intracavernosal injections; radical prostatectomy; sexual medicine

Indexed keywords

PAPAVERINE; PAPAVERINE PLUS PHENTOLAMINE; PAPAVERINE PLUS PHENTOLAMINE PLUS PROSTAGLANDIN E1; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADULT; AGED; COMORBIDITY; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ERECTILE DYSFUNCTION; FOLLOW UP; HOME MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL BODY RADIATION; PELVIS RADIOTHERAPY; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; SEXUAL INTERCOURSE; TERTIARY HEALTH CARE;

EID: 84870925043     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11080.x     Document Type: Review

References (31)

1. Virag R, Frydman D, Legman M, Virag H,. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology 1984; 35: 79-87
2. Brindley GS,. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. Br J Psychiatry 1986; 149: 210-5
3. Linet OI, Ogrinc FG,. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996; 334: 873-7
4. Dinsmore WW, Wyllie MG,. Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction. BJU Int 2008; 102: 933-7
5. Brindley GS,. Intrapenile drug delivery systems. Int J STD AIDS 1996; 7 (Suppl. 3): 13-5
6. Rooney M, Pfister W, Mahoney M, Nelson M, Yeager J, Steidle C,. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. J Sex Med 2009; 6: 520-34
7. Nandipati K, Raina R, Agarwal A, Zippe CD,. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res 2006; 18: 446-51
8. Mulhall JP,. Penile rehabilitation following radical prostatectomy. Curr Opin Urol 2008; 18: 613-20
9. Mulhall JP, Simmons J,. Assessment of comparative treatment satisfaction with sildenafil citrate and penile injection therapy in patients responding to both. BJU Int 2007; 100: 1313-6
10. Kim SC, Chang IH, Jeon HJ,. Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for >1 year. BJU Int 2003; 92: 277-80
11. Müller A, Parker M, Waters BW, Flanigan RC, Mulhall JP,. Penile rehabilitation following radical prostatectomy: predicting success. J Sex Med 2009; 6: 2806-12
12. Tal R, Mulhall JP,. Intracavernosal injections and fibrosis: myth or reality? BJU Int 2008; 102: 525-6
13. Perimenis P, Konstantinopoulos A, Perimeni PP, et al,. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. Asian J Androl 2006; 8: 219-24
14. Sanda MG, Dunn RL, Michalski J, et al,. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-61
15. Dubbelman YD, Dohle GR, Schröder FH,. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol 2006; 50: 711-20
16. Mottrie A, Van Migem P, De Naeyer G, Schatteman P, Carpentier P, Fonteyne E,. Robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases. Eur Urol 2007; 52: 746-50
17. Masterson TA, Wedmid A, Sandhu JS, Eastham JA,. Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non-prostate malignancies. BJU Int 2009; 104: 482-5
18. Raina R, Pahlajani G, Agarwal A, Zippe CD,. Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience. Int J Impot Res 2008; 20: 121-6
19. Deho F, Gallina A, Salonia A, et al,. Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitors. Curr Pharm Des 2009; 15: 3496-501
20. Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ,. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 2011; 25: 129-36
21. Moore CR, Wang R,. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 2006; 8: 675-84
22. Centers for Disease Control and Prevention. Diabetes Data & Trends. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figpersons. htm. Accessed 13 May 2011
23. Purvis K, Egdetveit I, Christiansen E,. Intracavernosal therapy for erectile failure-impact of treatment and reasons for drop-out and dissatisfaction. Int J Impot Res 1999; 11: 287-99
24. Mulhall JP, Jahoda AE, Cairney M, et al,. The causes of patient dropout from penile self-injection therapy for impotence. J Urol 1999; 162: 1291-4
25. Hsaio W, Bennett N, Guhring P, Narus J, Mulhall JP,. Satisfaction profiles in men using intracavernosal injection therapy. J Sex Med 2011; 8: 512-7
26. Narus J, Nelson CJ, Mulhall J,. Compliance with intracavernosal injection therapy in a post-radical prostatectomy penile rehabilitation program. American Urological Association Annual Meeting 2010. AUA, 2010. Abstract Number: 1007603
27. Burnett AL, Bivalacqua TJ,. Priapism: current principles and practice. Urol Clin North Am 2007; 34: 631-42
28. Kim NN, Kim JJ, Hypolite J, et al,. Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia. J Urol 1996; 155: 772-8
29. McMahon CG,. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy. Int J Impot Res 2003; 15: 383-4
30. Porst H,. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996; 155: 802-15
31. Mulhall JP,. Intracavernosal injection therapy: a practical guide. Tech Urol 1997; 3: 129-34